Oral polio vaccination during pregnancy: lack of impact on fetal development and perinatal outcome - PubMed (original) (raw)
Oral polio vaccination during pregnancy: lack of impact on fetal development and perinatal outcome
T Harjulehto-Mervaala et al. Clin Infect Dis. 1994 Mar.
Abstract
Prompted by a nascent epidemic of poliomyelitis in Finland, a mass vaccination program with live oral poliovirus vaccine (OPV) was implemented in February and March 1985. The final rate of coverage was approximately 94%. Pregnant women were included, and a cohort study was launched to evaluate any harmful effects of OPV on the developing embryo. All records of births to mothers who were pregnant during the period of vaccination and whose infants were delivered at the three major hospitals in the Helsinki area were reviewed. Within the study cohort, mothers were grouped into three categories according to their trimester of pregnancy during the program. In addition, two reference cohorts were evaluated; these cohorts consisted of infants delivered at the same hospitals during the second half of 1984 and of 1986, respectively. Each of the three categories in the study cohort included approximately 3,000 children, while each reference cohort included approximately 6,000 children. Data were analyzed on the rate of intrauterine growth and the prevalences of stillbirth, neonatal death, congenital malformation, premature birth, perinatal infection, and neurological aberration. No differences were documented among the study and reference cohorts or among the three categories within the study cohort. Thus, under the conditions described here, the inclusion of pregnant women in programs of mass vaccination with OPV appears to be safe.
Similar articles
- Congenital malformations and oral poliovirus vaccination during pregnancy.
Harjulehto T, Aro T, Hovi T, Saxén L. Harjulehto T, et al. Lancet. 1989 Apr 8;1(8641):771-2. doi: 10.1016/s0140-6736(89)92584-1. Lancet. 1989. PMID: 2564574 - Oral polio vaccination during pregnancy: no increase in the occurrence of congenital malformations.
Harjulehto-Mervaala T, Aro T, Hiilesmaa VK, Saxén H, Hovi T, Saxén L. Harjulehto-Mervaala T, et al. Am J Epidemiol. 1993 Sep 15;138(6):407-14. doi: 10.1093/oxfordjournals.aje.a116873. Am J Epidemiol. 1993. PMID: 8213746 - [Circulating vaccine-derived poliovirus type 2 outbreak in Democratic Republic of Congo 2011-2012].
Bazira L, Coulibaly T, Mayenga M, Ncharre C, Yogolelo R, Mbule A, Moudzeo H, Lwamba P, Mulumba AW, Cabore J. Bazira L, et al. Bull Soc Pathol Exot. 2015 Oct;108(4):235-41. doi: 10.1007/s13149-015-0447-4. Epub 2015 Aug 18. Bull Soc Pathol Exot. 2015. PMID: 26288132 French. - [Worldwide eradication of poliomyelitis].
Rasch G, Schreier E, Kiehl W, Kurth R. Rasch G, et al. Wien Klin Wochenschr. 2001 Oct 30;113(20-21):839-45. Wien Klin Wochenschr. 2001. PMID: 11732120 Review. German. - Risks associated with the use of live-attenuated vaccine poliovirus strains and the strategies for control and eradication of paralytic poliomyelitis.
Pliaka V, Kyriakopoulou Z, Markoulatos P. Pliaka V, et al. Expert Rev Vaccines. 2012 May;11(5):609-28. doi: 10.1586/erv.12.28. Expert Rev Vaccines. 2012. PMID: 22827246 Review.
Cited by
- Neonatal death: Case definition & guidelines for data collection, analysis, and presentation of immunization safety data.
Pathirana J, Muñoz FM, Abbing-Karahagopian V, Bhat N, Harris T, Kapoor A, Keene DL, Mangili A, Padula MA, Pande SL, Pool V, Pourmalek F, Varricchio F, Kochhar S, Cutland CL; Brighton Collaboration Neonatal Death Working Group. Pathirana J, et al. Vaccine. 2016 Dec 1;34(49):6027-6037. doi: 10.1016/j.vaccine.2016.03.040. Epub 2016 Jul 19. Vaccine. 2016. PMID: 27449077 Free PMC article. - A systematic review of adverse events following immunization during pregnancy and the newborn period.
Fulton TR, Narayanan D, Bonhoeffer J, Ortiz JR, Lambach P, Omer SB. Fulton TR, et al. Vaccine. 2015 Nov 25;33(47):6453-65. doi: 10.1016/j.vaccine.2015.08.043. Epub 2015 Sep 26. Vaccine. 2015. PMID: 26413879 Free PMC article. Review. - Congenital microcephaly: Case definition & guidelines for data collection, analysis, and presentation of safety data after maternal immunisation.
DeSilva M, Munoz FM, Sell E, Marshall H, Tse Kawai A, Kachikis A, Heath P, Klein NP, Oleske JM, Jehan F, Spiegel H, Nesin M, Tagbo BN, Shrestha A, Cutland CL, Eckert LO, Kochhar S, Bardají A; Brighton Collaboration Congenital Microcephaly Working Group. DeSilva M, et al. Vaccine. 2017 Dec 4;35(48 Pt A):6472-6482. doi: 10.1016/j.vaccine.2017.01.044. Vaccine. 2017. PMID: 29150052 Free PMC article. No abstract available. - Stillbirth: Case definition and guidelines for data collection, analysis, and presentation of maternal immunization safety data.
Tavares Da Silva F, Gonik B, McMillan M, Keech C, Dellicour S, Bhange S, Tila M, Harper DM, Woods C, Kawai AT, Kochhar S, Munoz FM; Brighton Collaboration Stillbirth Working Group. Tavares Da Silva F, et al. Vaccine. 2016 Dec 1;34(49):6057-6068. doi: 10.1016/j.vaccine.2016.03.044. Epub 2016 Jul 16. Vaccine. 2016. PMID: 27431422 Free PMC article. No abstract available. - Safety of Administering Live Vaccines During Pregnancy: A Systematic Review and Meta-Analysis of Pregnancy Outcomes.
Laris-González A, Bernal-Serrano D, Jarde A, Kampmann B. Laris-González A, et al. Vaccines (Basel). 2020 Mar 11;8(1):124. doi: 10.3390/vaccines8010124. Vaccines (Basel). 2020. PMID: 32168941 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical